NOVT vs VPG

Key Takeaways

• Novanta (NOVT) operates at a significantly larger scale, with nearly $981 million in full-year 2025 revenue compared to Vishay Precision Group (VPG) at $307 million, reflecting fundamentally different market footprints.
• Both companies serve precision-technology end markets, yet NOVT is heavily weighted toward medical and advanced industrial OEMs (original equipment manufacturers), while VPG is more diversified across test and measurement, industrial weighing, steel, and emerging robotics applications.
• NOVT delivered stronger profitability metrics in 2025, including an adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) margin above 22%, while VPG's comparable figure was approximately 9.2%, reflecting divergent operating leverage profiles.
• VPG has drawn investor attention for its early-stage exposure to humanoid robotics, generating $37.8 million in related orders during 2025, a narrative catalyst largely absent from NOVT's portfolio.
• NOVT carries a higher beta of approximately 1.64, indicating greater sensitivity to broader market swings, while VPG's beta near 0.89 suggests lower systematic volatility.
• On valuation, NOVT trades at a higher price-to-sales multiple than VPG, but its larger scale, higher margins, and stronger earnings trajectory may partially justify the premium.

Introduction

Investors navigating the precision-technology and industrial instrumentation space often encounter two distinct yet overlapping names: NOVT (Novanta Inc.) and VPG (Vishay Precision Group). Though both companies supply highly engineered components to demanding end markets, they differ markedly in scale, end-market exposure, profitability, and growth narrative. This comparison is relevant for traders and investors seeking to understand how a mid-cap medical-and-automation technology supplier stacks up against a smaller-cap precision measurement specialist, particularly at a time when industrial demand signals are mixed and AI-driven robotics themes are reshaping investor sentiment. The analysis below draws on recent financial results, market positioning, and observable momentum to offer a balanced, data-driven perspective.

NOVT Overview and Recent Performance

NOVT, Novanta Inc., is a trusted technology partner to medical and advanced industrial OEMs, specializing in photonics, vision, and precision motion solutions. The company operates through two primary segments: Automation Enabling Technologies and Medical Solutions, with the latter contributing roughly 55% of revenue. In recent weeks, Novanta reported full-year 2025 revenue of $980.6 million, up 3% year-over-year, and adjusted diluted EPS (earnings per share) of $3.29, an increase of nearly 7%. The fourth quarter showed accelerating momentum, with revenue climbing 9% to $258.3 million and adjusted EBITDA expanding 17% to $60.7 million. A return to positive organic growth, a 25% surge in customer bookings, and a book-to-bill ratio of 1.11x signaled healthy forward demand. The company's acquisition of Keonn, a Spain-based RFID (radio-frequency identification) and AI-powered inventory software provider, has performed ahead of plan. Management also guided for 2026 revenue between $1.03 billion and $1.05 billion, with adjusted EBITDA of $245 million to $250 million. These developments have contributed to a constructive sentiment around the stock, although a trailing P/E (price-to-earnings) ratio above 80 reflects elevated valuation expectations.

VPG Overview and Recent Performance

VPG, Vishay Precision Group, Inc., is a leader in precision measurement and sensing technologies, operating through three segments: Sensors, Weighing Solutions, and Measurement Systems. The company's products—including strain gages, force sensors, precision resistors, and specialized measurement equipment—serve industries ranging from transportation and steel production to aerospace and defense. For full-year 2025, VPG reported revenue of $307.2 million, essentially flat year-over-year, while adjusted diluted EPS dropped to $0.49 from $0.95 in 2024, reflecting broad-based margin compression. However, the company achieved five consecutive quarters of book-to-bill ratios at or above 1.00, with the Sensors segment recording its highest bookings since 2022 in the most recent quarter. A standout narrative has been VPG's emerging exposure to humanoid robotics, where orders linked to growth initiatives—including components for humanoid developers—reached $37.8 million in 2025, exceeding the company's $30 million target. Recent organizational changes, including the creation of two C-suite positions, underscore management's focus on accelerating growth. Still, gross margin headwinds from unfavorable product mix, inventory adjustments, and foreign exchange have weighed on profitability, contributing to a mixed market reception in recent weeks.

Trending AI Robots

In a market environment increasingly shaped by algorithmic decision-making, Tickeron's Trending AI Robots page offers traders a curated window into high-conviction automated strategies. Tickeron hosts hundreds of AI-powered trading bots that collectively scan thousands of tickers, but only a select subset—those demonstrating the strongest alignment with current market conditions—earn a spot in the Trending AI Robots section. These bots span a wide spectrum of trading styles, from short-term 5-minute and 15-minute agents to intermediate 60-minute swing-trading systems, with annualized returns among top-performing strategies ranging from approximately 78% to over 290% depending on the strategy and timeframe. Each bot operates with its own risk parameters, asset focus, and performance statistics—including Sharpe ratios, drawdown metrics, and profit factors—enabling users to evaluate them based on their individual trading preferences. For investors seeking to complement fundamental analysis with data-driven, AI-powered trade ideas, exploring the Trending AI Robots page may provide valuable, actionable context.

Head-to-Head Comparison

The contrast between NOVT and VPG is most visible along four dimensions: scale, profitability, growth narrative, and risk profile.

Scale and Market Position: NOVT's $981 million revenue base and $5.2 billion market capitalization dwarf VPG's $307 million in revenue and roughly $640 million market cap. NOVT serves large medical and industrial OEMs with deeply embedded, sole-sourced components that benefit from long design cycles and sticky revenue streams—approximately 750 patents support this moat. VPG, though respected in precision measurement, operates in more fragmented, cyclical end markets with smaller average contract sizes.

Profitability and Margins: NOVT's adjusted EBITDA margin of approximately 22.5% for 2025 meaningfully exceeds VPG's 9.2%. NOVT's medical segment, in particular, benefits from favorable pricing dynamics and regulatory barriers, while VPG has faced persistent gross margin pressure from mix shifts, inventory reductions, and currency headwinds. VPG's Measurement Systems segment does achieve gross margins above 50%, but it represents only a portion of the consolidated revenue base.

Growth Narrative: This is where VPG holds a differentiated appeal. The company's humanoid robotics orders of $37.8 million in 2025, while still a fraction of total revenue, position it at the frontier of an emerging technological theme—physical AI (artificial intelligence) and autonomous robotics. NOVT's growth story is more established and steady, driven by new product launches in advanced surgery, RFID expansion via the Keonn acquisition, and a robust M&A (mergers and acquisitions) pipeline, but it lacks the speculative upside associated with nascent end markets.

Risk and Volatility: NOVT's beta of 1.64 makes it significantly more sensitive to broad equity market moves. VPG's beta of 0.89 suggests it has historically traded with lower correlation to the S&P 500. Additionally, NOVT's regional manufacturing realignment, while strategically sound, has temporarily depressed operating cash flow—a factor investors are monitoring. VPG's risk factors include exposure to cyclical transportation, construction, and agriculture end markets.

Tickeron AI Verdict

Based on observable trends and relative positioning, Tickeron's AI-driven analytical framework would likely express a measured preference for NOVT in the current environment. The reasoning rests on several probabilistic factors: NOVT has demonstrated clearer momentum in earnings revisions, sustained margin leadership, a stronger balance sheet with net cash, and a more consistent book-to-bill trajectory. While VPG's humanoid robotics narrative offers an intriguing catalyst, the company's compressed profitability metrics and recent margin volatility introduce greater uncertainty into near-term trend consistency. That said, this assessment is not absolute—VPG's lower beta and early-stage robotics exposure could appeal to AI strategies optimized for lower-correlation, catalyst-driven setups. Ultimately, the AI verdict reflects a probabilistic tilt toward the stock exhibiting steadier fundamental momentum, but both tickers warrant ongoing monitoring as market conditions evolve.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations